NormanBGaylisMD

Rheumatology • Aventura, FL

Clinical Professor, Rheumatology, University of Miami Miller School of Medicine

Join to view full profile

Dr. Gaylis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gaylis' full profile

Already have an account?

Office
21097 NE 27th Crt
Suite 200
Aventura, FL 33180
Phone+1 305-652-6676

Fax+1 305-932-6335
Is this information wrong?

Summary

Dr. Norman Gaylis is a rheumatologist in Aventura, FL and is affiliated with Aventura Hospital and Medical Center. He received his medical degree from University of the Witwatersrand and has been in practice 44 years. He is experienced in systemic lupus erythematosus, osteoarthritis, rheumatoid arthritis, and gout.

Education & Training

University of Miami/Jackson Health SystemFellowship, Rheumatology, 1979 - 1981
Mount Sinai Medical Center of FloridaResidency, Internal Medicine, 1976 - 1979
University of the WitwatersrandClass of 1973

Certifications & Licensure

FL State Medical License 1977 - 2025
FL State Medical License Active through 2025
GA State Medical License Active through 1979
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Top Doctors:South Florida Castle Connolly, 2012
Top Doctors: Florida Castle Connolly, 2000
Fellow (FACR) American College of Rheumatology

Clinical Trials

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2007 Feb 01
Completed
Phase 2
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE) Start of enrollment: 2010 Jun 24
Completed
Phase 2
The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients Start of enrollment: 2010 Sep 01
Completed
Phase 3
Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients Start of enrollment: 2011 Jun 01
Completed
Phase 3
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients Start of enrollment: 2013 Sep 01
Completed
Phase 4
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
Completed
Phase 3
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Understanding immune dysregulation in post-acute sequelae of COVID-19 (PASC)-The hunt for effective treatments.
Norman B Gaylis, Otto O Yang> ;The Journal of Infection. 2024 Mar 24
'Totality of Evidence' Approach in the Development of GP2017, an Approved Adalimumab Biosimilar.
Charlotte Both, Lena Lemke, Oliver von Richter, Norman Gaylis, Paul Yamauchi> ;Advances in Therapy. 2024 Mar 21
A plain language summary describing how two different concentrations of GP2017, a biosimilar adalimumab medicine, are associated with similar drug levels within the body.
Silvio Danese, Piotr Wiland, Russell Cohen, Norman Gaylis, Charlotte Both, Shrihari Jathanakodi, Constanze Fey, Lena Lemke, Andrew Blauvelt> ;Immunotherapy. 2023 Dec 1
Reply to Viel.
Christopher Recknor, Scott G Hansen, Norman B Gaylis, Meenakshi Tiwary, Jonah B Sacha, Otto O Yang> ;Clinical Infectious Diseases. 2022 Oct 12
6 citations
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
Norman B Gaylis, Angela Ritter, Scott A Kelly, Nader Z Pourhassan, Meenakshi Tiwary, Jonah B Sacha, Scott G Hansen, Christopher Recknor, Otto O Yang> ;Clinical Infectious Diseases. 2022 Sep 30
2 citations
The results of a unique dietary supplement (nutraceutical formulation) used to treat the symptoms of long-haul COVID.
Norman B Gaylis, Ida Kreychman, Joanne Sagliani, Josef Mograbi, Yankel Gabet> ;Frontiers in Nutrition. 2022 Jan 1
Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther...
Andrew J. Holman, Edward C. Keystone, Ernest Choy, Daniel E. Furst, Peter C. Taylor, Norman Gaylis> ;Rheumatology and Therapy. 2021 Nov 10
5 citations
Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measure...
Andrew Blauvelt, Craig L. Leonardi, Norman Gaylis, Julia Jauch-Lembach, Alison Balfour, Lena Lemke, Sohaib Hachaichi, Ines Brueckmann, Teodora Festini, Piotr Wiland> ;Biodrugs. 2021 Mar 2
23 citations
Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III...
Piotr Wiland, Sławomir Jeka, Eva Dokoupilova, Jan Brandt-Jürgens, Juan Manuel Miranda Limon, Miguel Cantalejo Moreira, Raul Maria Veiga Cabello, Julia Jauch-Lembach, A...> ;Biodrugs. 2020 Dec 1
32 citations
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage mult...
Genovese, M., Gaylis, N., Sikes, D., Kivitz, A., Lewis Horowitz, D., Peterfy, C., Glass, E., Levine, Y., Chernoff, D.> ;The Lancet. Rheumatology. 2020 Sep 1
9 citations
Patient Perspectives on Intravenous Biologics for Rheumatologic Disease.
Lucas Grisanti, Alysia Kwiatkowski, Peter Dyrda, Ellen Field, Joseph Grisanti, James E. Hatem, Raphael J. DeHoratius, Norman B. Gaylis> ;Arthritis Care & Research. 2019 Sep 1
4 citations
Patient-reported outcome assessment of inflammatory arthritis patient experience with intravenously administered biologic therapy
Norman B. Gaylis, Joanne Sagliani, Shawn Black, Kezhen L. Tang, Raphael J. DeHoratius, Wesley A. Kafka, D. Parenti> ;Patient Preference and Adherence. 2017 Sep 12
Convergent Validity of New Disease Assessment Instruments (Dai) In Systemic Lupus Erythematosus (Sle) In Relation to Sledai-2k.
Narayanan, S.,Collins, C. E.,Busch, H. M.,Gaylis, N.,Hautamaki, E.,Chatham, W. W.> ;Value Health. 2015 Nov 05
1 citations
Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conference.
Orrin M Troum, Olga L Pimienta, Wolfgang A Schmidt, Mikkel Ostergaard, Maria Antonietta D'Agostino, Norman Gaylis, William Arnold, Ami Ben-Artzi, Veena Ranganath, Judy...> ;Seminars in Arthritis and Rheumatism. 2015 Aug 1
40 citations
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the mult...
Josef S Smolen, Jonathan Kay, Mittie K. Doyle, Robert Landewé, Eric L. Matteson, Norman Gaylis, Jürgen Wollenhaupt, Frederick T Murphy, Stephen Xu, Yiying Zhou, Elizab...> ;Arthritis Research & Therapy. 2015 Jan 22
The value of magnetic resonance imaging in clinical practice.
Norman B. Gaylis> ;Journal of Clinical Rheumatology. 2014 Jun 1
22 citations
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study.
Charles H. Pritchard, Maria Greenwald, Joel M. Kremer, Norman B Gaylis, William F. C. Rigby, Steve Zlotnick, Carol Chung, Birgit Jaber, W. Reiss> ;BMC Musculoskeletal Disorders. 2014 May 24
35 citations
Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932)
Charles Peterfy, Ewa Olech, Julie C DiCarlo, Joan T. Merrill, Peter Countryman, Norman Gaylis> ;Arthritis Research & Therapy. 2013 Mar 20
32 citations
Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI
Charles Peterfy, Julie C DiCarlo, Ewa Olech, Maire-Agnes Bagnard, Annarita Gabriele, Norman Gaylis> ;Arthritis Research & Therapy. 2012 May 30
13 citations
Long-term follow-up of an HIV-infected patient with reactive arthritis treated with infliximab.
Norman B. Gaylis> ;Journal of Clinical Rheumatology. 2012 Apr 1
45 citations
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a re...
Paul Emery, Philip J. Mease, Andrea Rubbert-Roth, Jeffrey R. Curtis, Ulf Müller-Ladner, Norman B Gaylis, Sarah Williams, Mark Reynard, Helen Tyrrell> ;Rheumatology. 2011 Sep 16
14 citations
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience.
Charles Peterfy, Peter Countryman, Annarita Gabriele, T. Shaw, Andrew Anisfeld, Wayne Tsuji, Ewa Olech, Norman Gaylis, Philip G. Conaghan, Vibeke Strand, Julie C DiCarlo> ;The Journal of Rheumatology. 2011 Sep 1
91 citations
Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRIS...
Philip J. Mease, Stanley Cohen, Norman B Gaylis, Andrew Chubick, Alan Kaell, Maria Greenwald, Sunil Agarwal, Ming Yin, Ariella Kelman> ;The Journal of Rheumatology. 2010 May 1
415 citations
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-bli...
Josef S Smolen, Jonathan Kay, Mittie K. Doyle, Robert Landewé, Eric L. Matteson, Jürgen Wollenhaupt, Norman Gaylis, Frederick T. Murphy, Jeffrey S Neal, Yiying Zhou, S...> ;Lancet. 2009 Jul 18
2 citations
In-office magnetic resonance imaging to monitor responses to therapy in rheumatoid arthritis.
Norman B. Gaylis, Steven D. Needell> ;Rheumatology International. 2009 Apr 22
Join now to see all

Press Mentions

COVID-19 Nasal Spray Shows Strong Immune Response in StudyApril 7th, 2023
COVID Vaccine Nasal Spray Shows Strong Immune Response in Study: ‘Could Be a Game Changer’April 6th, 2023
5 Questions to Ask Your Doctor for a COVID-19 Treatment Strategy (Before Infection)April 3rd, 2023
Join now to see all